Bring your product to market with impact.
Whether you’re preparing to commercialize a new product or expand an existing one, our go-to-market approach brings clarity to the market opportunity and the execution required to capture it. We translate insights into focused plans that align development, access, and commercial efforts. From pre-launch through early growth, we help teams enter the market with confidence and direction.
Meet the experts behind the solutions delivering meaningful impact for our clients.
As President of Putnam, Matt leads a team focused on strategic acuity and patient impact. He has partnered with global biopharma across therapeutic areas from pipeline shaping to launch, applying structured thinking and objective analysis to drive results.
Karan sits on Putnam’s Commercial Practice Leadership team, advising US and European biopharma on pipeline and in-line products. His focus includes go-to-market strategy, opportunity assessment, forecasting, and portfolio optimization.
Access the most up-to-date health and life sciences insights and resources.
Designing a new GTM model for an ambitious upcoming oncology launch.
The COVID-19 pandemic has not only driven an increased appetite and need for digital transformation.
Over the last decade, rare diseases have represented an increasingly popular growth avenue to offset the challenges faced in other mature franchises.
Agentic AI–powered launch command centers predict pharma launch risks and enable faster, smarter decisions for successful product launches.
Let’s discuss how we can help you.